Current Neuro-Oncology
Volume
26 Number 5
15 March 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 5, 15 March
*Cioffi G, Waite KA, Dmukauskas M, Glantz M, Aulakh S, Nicolaides
T, Sengupta S, Xiu J, Barnholtz-Sloan JS.
Sex
differences in glioblastoma response to treatment: Impact of MGMT
methylation.
Neurooncol
Adv. 2024 Mar 1;6(1):vdae031. doi:
10.1093/noajnl/vdae031. PMID:
38476929. Observational study. ˍ
de Blank PMK, Lange KR, Xing M, Mirzaei Salehabadi S, Srivastava
D, Brinkman TM, Ness KK, Oeffinger KC, Neglia J, Krull KR, Nathan
PC, Howell R, Turcotte LM, Leisenring W, Armstrong GT, Okcu MF,
Bowers DC.
Temporal changes in
treatment and late mortality and morbidity in adult survivors of
childhood glioma: a report from the Childhood Cancer Survivor
Study.
Nat
Cancer. 2024 Mar 1. doi:
10.1038/s43018-024-00733-0. PMID:
38429413. Observational study˰
ˍ
Tsang DS, Tsui G, Santiago AT, Keller H, Purdie T, Mcintosh C,
Bauman G, La Macchia N, Parent A, Dama H, Ahmed S, Laperriere N,
Millar BA, Liu V, Hodgson DC.
A
Prospective Study of Machine Learning-Assisted Radiotherapy
Planning for Patients Receiving 54 Gy to the Brain.
Int
J Radiat Oncol Biol Phys. 2024 Mar
1:S0360-3016(24)00334-1. doi:
10.1016/j.ijrobp.2024.02.022. PMID:
38432285. Observational study. ˍ
Mankuzhy NP, Tringale KR, Dunkel IJ, Farouk Sait S, Souweidane MM,
Khakoo Y, Karajannis MA, Wolden S.
Hypofractionated
re-irradiation for diffuse intrinsic pontine glioma.
Pediatr
Blood Cancer. 2024 Mar 2:e30929. doi:
10.1002/pbc.30929. PMID:
38430472. Observational study. ˍ
Lai S, Li P, Liu X, Liu G, Xie T, Zhang X, Wang X, Huang J, Tang
Y, Liu Z, Shen G, Li C, Lu F, Wang L, Jiang F, Sun C, Chen Y, Chen
M.
Efficacy and safety of anlotinib
combined with the STUPP regimen in patients with newly diagnosed
glioblastoma: a multicenter, single-arm, phase II trial.
Cancer
Biol Med. 2024 Mar 4:j.issn.2095-3941.2023.0373. doi:
10.20892/j.issn.2095-3941.2023.0373. PMID:
38445445. Interventional study. ˍ
Cacciotti C, Lenzen A, Self C, Pillay-Smiley N.
Recurrence
Patterns and Surveillance Imaging in Pediatric Brain Tumor
Survivors.
J
Pediatr Hematol Oncol. 2024 Mar 5. doi:
10.1097/MPH.0000000000002850. PMID:
38447113. Observational study. ˍ
Arrillaga-Romany I, Lassman A, McGovern SL, Mueller S, Nabors B,
van den Bent M, Vogelbaum M, Allen JE, Melemed AS, Tarapore RS,
Wen PY, Cloughesy T.
ACTION: A
randomized phase 3 study of ONC201 (dordaviprone) in patients with
newly diagnosed H3 K27M-mutant diffuse glioma.
Neuro
Oncol. 2024 Mar 6:noae031. doi:
10.1093/neuonc/noae031. PMID:
38445964. Interventional study. ˍ
*Alberghina C, Torrisi F, D'Aprile S, Longhitano L, Giallongo S,
Scandura G, Mannino G, Mele S, Sabini MG, Cammarata FP, Russo G,
Abdelhameed AS, Zappalà A, Lo Furno D, Giuffrida R, Li
Volti G, Tibullo D, Vicario N, Parenti R.
Microglia
and glioblastoma heterocellular interplay sustains tumour growth
and proliferation as an off-target effect of radiotherapy.
Cell
Prolif. 2024 Mar 7:e13606. doi:
10.1111/cpr.13606. PMID:
38454614. Laboratory investigation. ˍ
Brown CE, Hibbard JC, Alizadeh D, Blanchard MS, Natri HM, Wang D,
Ostberg JR, Aguilar B, Wagner JR, Paul JA, Starr R, Wong RA, Chen
W, Shulkin N, Aftabizadeh M, Filippov A, Chaudhry A, Ressler JA,
Kilpatrick J, Myers-McNamara P, Chen M, Wang LD, Rockne RC,
Georges J, Portnow J, Barish ME, D'Apuzzo M, Banovich NE, Forman
SJ, Badie B.
Locoregional delivery of
IL-13Rα2-targeting CAR-T cells in recurrent high-grade
glioma: a phase 1 trial.
Nat
Med. 2024 Mar 7. doi:
10.1038/s41591-024-02875-1. PMID:
38454126. Interventional study. ˍ
Breen WG, Geno CS, Waddle MR, Qian J, Harmsen WS, Burns TC, Sener
UT, Ruff MW, Neth BJ, Uhm JH, Routman DM, Yan E, Kruse JJ, Laack
NN, Brown PD, Mahajan A.
Proton versus
photon craniospinal irradiation for adult medulloblastoma: A
dosimetric, toxicity, and exploratory cost analysis.
Neurooncol
Adv. 2024 Mar 8;6(1):vdae034. doi:
10.1093/noajnl/vdae034. PMID:
38550393. Observational study. ˍ
Di Nunno V, Lombardi G, Simonelli M, Minniti G, Mastronuzzi A, Di
Ruscio V, Corrà M, Padovan M, Maccari M, Caccese M,
Simonetti G, Berlendis A, Farinotti M, Pollo B, Antonelli M, Di
Muzio A, Dipasquale A, Asioli S, De Biase D, Tosoni A, Silvani A,
Franceschi E.
The role of adjuvant
chemotherapy in patients with H3K27 altered diffuse midline
gliomas: a multicentric retrospective study.
J
Neurooncol. 2024 Mar 8. doi:
10.1007/s11060-024-04589-3. PMID:
38457090. Observational study˰
ˍ
Komlodi-Pasztor E, Munjapara V, Eberhart CG, Bazer DA, Sherief MR,
Kamson DO, Ye X, Ozer BH, Holdhoff M.
Postradiation
platinum-etoposide in adult medulloblastomas: retrospective
analysis of hematological toxicity.
CNS
Oncol. 2024 Mar 8:CNS107. doi:
10.2217/cns-2023-0029. PMID:
38456492. Observational study. ˍ
Lenga P, Kleineidam H, Unterberg A, Dao Trong P.
Optimizing
patient outcome in intracranial tumor surgery: a detailed
prospective study of adverse events and mortality reduction
strategies in neurosurgery.
Acta
Neurochir (Wien). 2024 Mar 8;166(1):126. doi:
10.1007/s00701-024-06008-y. PMID:
38457057. Observational study. ˍ
Hudson EM, Noutch S, Webster J, Brown SR, Boele FW, Al-Salihi O,
Baines H, Bulbeck H, Currie S, Fernandez S, Hughes J, Lilley J,
Smith A, Parbutt C, Slevin F, Short S, Sebag-Montefiore D, Murray
L.
Brain Re-Irradiation Or
Chemotherapy: a phase II randomised trial of re-irradiation and
chemotherapy in patients with recurrent glioblastoma (BRIOChe) -
protocol for a multi-centre open-label randomised trial.
BMJ
Open. 2024 Mar 8;14(3):e078926. doi:
10.1136/bmjopen-2023-078926. PMID:
38458809. Interventional study protocol. ˍ
Ying Z, Yang W, Zhang N, Sun H, Zhang D, Shang B, Chen J, Ge
M.
Risk factors for postoperative
ventriculoperitoneal shunt requirement in pediatric patients with
brain tumors invading or adjacent to CSF circulation pathways.
J
Neurosurg Pediatr. 2024 Mar 8:1-8. doi:
10.3171/2024.1.PEDS23225. PMID:
38457814. Observational study˰
ˍ
Moreira DC, Qaddoumi I, Spiller S, Bouldin TW, Davidson A,
Saba-Silva N, Sullivan DV, Tanaka R, Wagner AS, Wood M, Klimo P,
Job G, Devidas M, Li X, Gajjar A, Robinson GW, Chiang
J.
Comprehensive analysis of
MYB/MYBL1-altered pediatric-type diffuse low-grade glioma.
Neuro
Oncol. 2024 Mar 11:noae048. doi:
10.1093/neuonc/noae048. PMID:
38466086. Observational study.
ˍ
Morin A, Allodji R, Kariyawasam D, Touraine P, Puget S, Beccaria
K, De Carli E, Kieffer V, Rivollet S, Abbou S, Fayech C, Souchard
V, Dufour C, De Vathaire F, Bolle S, Grill J, Fresneau B.
Very
long-term outcomes of pediatric patients treated for optic pathway
gliomas: A longitudinal cohort study.
Neuro
Oncol. 2024 Mar 11:noae045. doi:
10.1093/neuonc/noae045. PMID:
38465768. Observational study˰
ˍ
Thomas-Joulié A, Tran S, El
Houari L, Seyve A, Bielle F, Birzu C, Lozano-Sanchez F, Mokhtari
K, Giry M, Marie Y, Laigle-Donadey F, Dehais C, Houillier C,
Psimaras D, Alentorn A, Laurenge A, Touat M, Sanson M, Hoang-Xuan
K, Kas A, Rozenblum L, Habert MO, Nichelli L, Leclercq D, Galanaud
D, Jacob J, Karachi C, Capelle L, Carpentier A, Mathon B, Belin L,
Idbaih A.
Prognosis
of glioblastoma patients improves significantly over time
interrogating historical controls.
Eur
J Cancer. 2024
Mar 11;202:114004. doi:
10.1016/j.ejca.2024.114004. PMID:
38493668. Observational study. ˍ
*Coman DL, Chard MP, Desautels L, Lutz BJ, Minns LA.
What
do spouse primary caregivers of patients with glioblastoma want
medical providers to know? A qualitative thematic reflexive
analysis of letters written by primary caregivers from a secret
Facebook support group.
BMJ
Open. 2024 Mar 12;14(3):e081783. doi:
10.1136/bmjopen-2023-081783. PMID:
38479741. Observational study.
ˍ
Ek L, Elwin M, Neander K.
Neuropsychological
longitudinal study of patients with low-grade gliomas: Cognitive
impairment.
Appl
Neuropsychol Adult. 2024 Mar 12:1-11. doi:
10.1080/23279095.2024.2325546. PMID:
38470840. Observational study˰
ˍ
Liu Y, Hu H, Han Y, Li Z, Yang J, Zhang X, Chen L, Chen F, Li W,
Huang G.
Development and external
validation of a novel score for predicting postoperative 30‑day
mortality in tumor craniotomy patients: A cross-sectional
diagnostic study.
Oncol
Lett. 2024 Mar 12;27(5):205. doi:
10.3892/ol.2024.14338. PMID:
38516688. Observational study.
ˍ
Bagley SJ, Logun M, Fraietta JA, Wang X, Desai AS, Bagley LJ,
Nabavizadeh A, Jarocha D, Martins R, Maloney E, Lledo L, Stein C,
Marshall A, Leskowitz R, Jadlowsky JK, Christensen S, Oner BS,
Plesa G, Brennan A, Gonzalez V, Chen F, Sun Y, Gladney W, Barrett
D, Nasrallah MP, Hwang WT, Ming GL, Song H, Siegel DL, June CH,
Hexner EO, Binder ZA, O'Rourke DM.
Intrathecal
bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent
glioblastoma: phase 1 trial interim results.
Nat
Med. 2024 Mar 13. doi:
10.1038/s41591-024-02893-z. PMID:
38480922. Interventional study˰
ˍ
Cipri S, Del Baldo G, Carai A, Cacchione A, Agolini E, Novelli A,
Rossi S, Colafati GS, Boccuto L, Mastronuzzi A.
A
second case report of medulloblastoma in a patient carrying
biallelic pathogenic MUTYH germline variants.
Neuropathol
Appl Neurobiol. 2024 Mar 13;50(2):e12968. doi:
10.1111/nan.12968. PMID:
38477379. Case report. ˍ
Edelbach B, Gospodarev V, Lopez-Gonzalez M, Deisch J, Kaur
M.
Unusual presentation of glioblastoma
in the brainstem: a case report of a diffuse pontine glioblastoma
multiforme and surgical management.
Front
Oncol. 2024 Mar 13;14:1279897. doi:
10.3389/fonc.2024.1279897. PMID:
38544840. Case report. ˍ
Özkan A, Yağcı Küpeli B, Küpeli S, Sezgin
G, Bayram İ.
Nimotuzumab-vinorelbine
combination therapy versus other regimens in the treatment of
pediatric diffuse intrinsic pontine glioma.
Childs
Nerv Syst. 2024 Mar 13. doi:
10.1007/s00381-024-06329-4. PMID:
38478066. Observational study˰
ˍ
Ebaid NY, Ahmed RN, Assy MM, Amin MI, Eldin AMA, Alsowey AM,
Abdelhay RM.
Diagnostic Validity and
Reliability of BT-RADS in the Management of Recurrent High-Grade
Glioma.
J
Neuroradiol. 2024 Mar 14:S0150-9861(24)00111-1. doi:
10.1016/j.neurad.2024.03.001. PMID:
38492800. Observational study˰
ˍ
Soni N, Agarwal A, Ajmera P, Mehta P, Gupta V, Vibhute M,
Gubbiotti M, Mark IT, Messina SA, Mohan S, Bathla G.
High-Grade
Astrocytoma with Piloid Features: A Dual Institutional Review of
Imaging Findings of a Novel Entity.
AJNR
Am J Neuroradiol. 2024 Mar 14. doi:
10.3174/ajnr.A8166. PMID:
38485198. Observational study˰
ˍ
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa
S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli
I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori
S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri
S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L,
Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G.
REGOMA-OSS:
a large, Italian, multicenter, prospective, observational study
evaluating the efficacy and safety of regorafenib in patients with
recurrent glioblastoma.
ESMO
Open. 2024 Mar 15;9(4):102943. doi:
10.1016/j.esmoop.2024.102943. PMID:
38492275. Observational study.
ˍ
Casper D, Hayden J, Anthony M, Matthees N, Mushtaq R.
GammaTile:
Reshaping Brachytherapy.
Radiol
Imaging Cancer. 2024 Mar 15;6(2):e230208. doi:
10.1148/rycan.230208. PMID:
38488499. Case report. ˍ
Honeyman SI, Owen WJ, Mier J, Marks K, Dassanyake SN, Wood MJ,
Fairhead R, Martinez-Soler P, Jasem H, Yarlagadda A, Roach JR,
Boukas A, Stacey R, Apostolopoulos V, Plaha P.
Multiple
surgical resections for progressive IDH wildtype glioblastoma-is
it beneficial?
Acta
Neurochir (Wien). 2024 Mar 15;166(1):138. doi:
10.1007/s00701-024-06025-x. PMID:
38488994. Observational study.
ˍ
Mude P, Pradhan M, Tiwari A, Parida TK, Nayak MK, Sekar AK,
Purkait S, Devi U.
Congenital brain
tumour in a neonate: a therapeutic challenge.
BMJ
Case Rep. 2024 Mar 15;17(3):e259646. doi:
10.1136/bcr-2024-259646. PMID:
38490704. Case report. ˍ